Document Detail


Half-dose aprotinin does not affect haemorheological properties in patients undergoing bypass surgery.
MedLine Citation:
PMID:  8922889     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To investigate haemorheological changes in patients undergoing coronary artery bypass grafting and to determine whether the protective effect on haemorheology of high-dose aprotinin also exists under a half-dose regimen. METHODS: Forty patients were studied in a double-blind, placebo-controlled study design. Patients in the aprotinin group received half of the standard high dose of aprotinin during surgery. Erythrocyte and white-cell clogging rates as well as whole blood and plasma viscosity were measured. Viscosity results were expressed as a ratio to the viscosity of saline. RESULTS: Erythrocyte and white-cell clogging rates were increased significantly, whereas whole blood and plasma viscosity were decreased significantly during cardiopulmonary bypass. The reduction in viscosity had a strong correlation to haemodilution. There was no significant difference in any of the measured variables between the aprotinin and the placebo groups. CONCLUSION: This study showed that blood cell damage occurred during cardiopulmonary bypass surgery, as measured by a raised clogging rate. This tendency was the same in both groups and therefore no increased potential for microthrombi could be attributed to aprotinin haemorheologically. However, half-dose aprotinin did not show any preserving effect in haemorheology when the blood-cell clogging rate and blood viscosity were studied.
Authors:
B Liu; A Belboul; G Rådberg; L Dernevik; Z Liang; E Berglin; D Roberts
Related Documents :
20627109 - Multiple equilibrium states in a micro-vascular network.
2789779 - Blood viscosity and hearing levels in the caerphilly collaborative heart disease study.
8310679 - Half-strength citrate cpd combined with a new additive solution for improved storage of...
1203539 - Contrasting splenic mechanisms in the blood clearance of red blood cells and colloidal ...
16525569 - Gender differences in the expression of erythrocyte aggregation in relation to b beta-f...
20203369 - Does carbonyl stress cause increased blood viscosity during storage?
14663339 - Determination of kinetic rate constants for 2-[18f]fluoro-2-deoxy-d-glucose and partiti...
11728549 - Abnormal microcirculation in brain tumours during surgery.
8172859 - Annexin v inhibits the procoagulant activity of matrices of tnf-stimulated endothelium ...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Coronary artery disease     Volume:  7     ISSN:  0954-6928     ISO Abbreviation:  Coron. Artery Dis.     Publication Date:  1996 Aug 
Date Detail:
Created Date:  1997-02-26     Completed Date:  1997-02-26     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9011445     Medline TA:  Coron Artery Dis     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  609-13     Citation Subset:  IM    
Affiliation:
Department of Cardiothoracic Surgery, Sahlgrenska Hospital, University of Gothenburg, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aprotinin / administration & dosage,  therapeutic use*
Blood Coagulation / drug effects*
Blood Viscosity / drug effects*
Coronary Artery Bypass*
Dose-Response Relationship, Drug
Double-Blind Method
Female
Hemostatics / administration & dosage,  therapeutic use*
Humans
Male
Middle Aged
Reference Values
Treatment Outcome
Chemical
Reg. No./Substance:
0/Hemostatics; 9087-70-1/Aprotinin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Subcutaneous infusion of r-hirudin does not inhibit neointimal proliferation after angioplasty of th...
Next Document:  Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function...